Abnormal Cardiac Magnetic Resonance Imaging Mapping Parameters in Pediatric Heart Transplant Patients with Elevated Donor-Derived Cell Free DNA - Takeaways - MDSpire

Abnormal Cardiac Magnetic Resonance Imaging Mapping Parameters in Pediatric Heart Transplant Patients with Elevated Donor-Derived Cell Free DNA

  • By

  • Kae Watanabe

  • Defne A. Magnetta

  • Christina Laternser

  • Alona Birjiniuk

  • Joshua D. Robinson

  • Cynthia K. Rigsby

  • Nazia Husain

  • July 9, 2026

  • 0 min

Share

  • 1

    Heart transplant is the gold standard for end-stage heart failure in pediatric patients.

  • 2

    Donor-derived cell-free DNA (ddcfDNA) is increasingly used for non-invasive rejection surveillance in heart transplant recipients.

  • 3

    Multiparametric cardiac magnetic resonance imaging (CMR) allows comprehensive tissue characterization of the myocardium.

  • 4

    The study included 68 pediatric heart transplant patients, with 54 in the low ddcfDNA group and 14 in the high group.

  • 5

    Higher levels of ddcfDNA were associated with older age, increased history of cardiac allograft vasculopathy, and moderate/severe rejection.

Original Source(s)

Abnormal Cardiac Magnetic Resonance Imaging Mapping Parameters in Pediatric Heart Transplant Patients with Elevated Donor-Derived Cell Free DNA

  • by Kae Watanabe, Defne A. Magnetta, Christina Laternser, Alona Birjiniuk, Joshua D. Robinson, Cynthia K. Rigsby, Nazia Husain

  • July 9, 2026

Related Content

Application of predicting risk of cardiovascular disease events equations on postoperative major adverse cardiac and cerebral events for patients undergoing thoracic surgery

Patterns of temporary mechanical circulatory support, escalation, de-escalation and outcomes in cardiogenic shock

Editorial: introducing special collection on cancer and cardiovascular disorders